GlassScriptPhysician profile
Christopher R Phillips
NPI 1912024563
$15,511.92
in general payments reported to CMS, 2019-2025
39 companies · $1,834 in 2025
The $1,834 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,604 · 2020: $1,241 · 2021: $5,405 · 2022: $1,877 · 2023: $1,914 · 2024: $1,637 · 2025: $1,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,384.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,365.22 | 2019-2025 | |
| Amgen INC. | $2,759.42 | 2019-2025 | Tavneos, Enbrel, Krystexxa |
| Ucb, INC. | $2,473.02 | 2019-2025 | Cimzia, Bimzelx |
| Abbvie INC. | $996.14 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $872.88 | 2019-2025 | |
| Horizon Therapeutics Plc | $722.14 | 2019-2023 | Krystexxa |
| Janssen Biotech, INC. | $382.61 | 2019-2025 | Simponi Aria, Remicade, Stelara |
| Lilly USA, LLC | $298.06 | 2019-2024 | Taltz |
| Glaxosmithkline, LLC. | $270.32 | 2019-2024 | Benlysta |
| Mallinckrodt Hospital Products INC. | $242.67 | 2021-2025 | Acthar |
| Organon LLC | $203.61 | 2021-2025 | Renflexis, Hadlima, Nexplanon |
| Genentech USA, INC. | $200.64 | 2019-2025 | Actemra, Gazyva |
| E.R. Squibb & Sons, L.L.C. | $199.27 | 2019-2025 | Orencia |
| Sandoz INC. | $183.61 | 2023-2025 | Hyrimoz |
| Astrazeneca Pharmaceuticals LP | $183.50 | 2021-2025 | Saphnelo |
Show all 38 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.